A panelist discusses how ongoing research into next-generation DMD therapies aims to improve delivery methods, develop better vectors that can carry larger dystrophin genes, and determine optimal treatment timing, with evidence suggesting earlier …

A panelist discusses how DMD progression affects different muscle groups over time, with the most serious complications involving respiratory and cardiac muscles, necessitating specialized care from pulmonologists and cardiologists.

… Gala in partnership with the Muscular Dystrophy Association (MDA) on June 23 … development of transformative treatments for muscular dystrophy, ALS and more than 300 … the legacy of progress that Muscular Dystrophy Association has built over the …

… most common form of adult muscular dystrophy, is a progressive, inherited … ### About the Myotonic Dystrophy Foundation The Myotonic Dystrophy Foundation (MDF) is … organization focused solely on myotonic dystrophy (DM). Through advocacy, education, …

… Gala in partnership with the Muscular Dystrophy Association (MDA) on June 23 … development of transformative treatments for muscular dystrophy, ALS, and more than 300 … the legacy of progress that Muscular Dystrophy Association has built over the …

… routine echocardiographic monitoring for muscular dystrophy patients, typically on … to mortality in muscular dystrophies, including Duchenne muscular dystrophy (DMD), … , Becker muscular dystrophy, limb-girdle muscular dystrophy, or myotonic dystrophy who were …

… in development for limb-girdle muscular dystrophy Type 2E (LGMD2E/R4 … therapy intended to treat Duchenne muscular dystrophy (DMD).2 “This is one … recently presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific …

… of transformative treatments for muscular dystrophy, ALS, and more … Dailey, Chief Development Officer, Muscular Dystrophy Association. CITGO – MDA events … CITGO Holding, Inc. About Muscular Dystrophy Association Muscular Dystrophy Association (MDA) is the …